Innvolution Healthcare

Innvolution Healthcare Innvolution is committed to bringing cutting edge technologies & solutions to improve standard of ca

ALCHEMY transformed clinical belief into compelling clinical evidence.In a real-world, all-comer study of 1000 patients ...
22/05/2026

ALCHEMY transformed clinical belief into compelling clinical evidence.

In a real-world, all-comer study of 1000 patients across 22 centers in India, Eternia has demonstrated outcomes that truly matter in today’s complex PCI practice.

From STEMI and multivessel disease to long lesions and high-risk diabetic patients, Eternia demonstrated consistent safety, dependable performance, and clinical confidence.

1-Year Clinical Outcomes of ALCHEMY:

* DOCE: 1.9%
* POCE: 3.3%
* Target Vessel Failure: 2.7%
* Stent Thrombosis: 0.5%

The successful presentation of ALCHEMY at EuroPCR 2026 marks a proud milestone for Innvolution Healthcare and highlights our commitment towards science, innovation, and evidence-driven cardiology.

Heartfelt gratitude to all Principal Investigators and participating centres who made this landmark achievement possible.

Note: This communication is intended for healthcare professionals (HCPs) in India and is for informational purposes only. It is not intended to provide medical advice or serve as a substitute for the independent medical judgment of an HCP.

Reach farther, navigate smoother & perform better.Presenting Xtrack Intracranial Distal Access Catheter — redefining dis...
22/05/2026

Reach farther, navigate smoother & perform better.

Presenting Xtrack Intracranial Distal Access Catheter — redefining distal reachability with precision & performance.

Available in 5F & 6F & Lengths: 115 cm, 125 cm & 135 cm.

Note: This communication is intended for healthcare professionals (HCPs) in India and is for informational purposes only. It is not intended to provide medical advice or serve as a substitute for the independent medical judgment of an HCP.

18/05/2026

LAD Total Occlusion

A 46-year-old male patient was evaluated for coronary artery disease. Angiographic findings revealed a critical 95–99% total occlusion in the LAD artery. The distal LCX showed a long segment 70–80% stenosis, and the major OM branch demonstrated 70–80% stenosis, while the right coronary artery appeared normal. Based on these findings, PTCA to the LAD was planned.

The procedure was performed via the right radial approach using a 6F guiding catheter and a 0.014” guidewire to successfully cross the LAD lesion. Sequential balloon pre-dilatation was carried out to prepare the vessel, followed by deployment of two DES stents measuring 2.75 × 26 mm in the proximal segment and 2.5 × 48 mm in the distal segment under precise fluoroscopic guidance. Post-dilatation was performed to ensure optimal stent expansion and apposition. Final angiography confirmed satisfactory TIMI flow with successful restoration of blood flow across the treated vessel.

Innvolution’s Premier Elite Cath Lab system played a vital role by delivering high-resolution real-time fluoroscopic imaging, enhanced procedural visualization, smooth device navigation, and accurate stent deployment, contributing to the successful restoration of blood flow throughout the intervention.

Note: This communication is intended for healthcare professionals (HCPs) in India and is for informational purposes only. It is not intended to provide medical advice or serve as a substitute for the independent medical judgment of an HCP.

15/05/2026

Percutaneous Balloon Pulmonary Valvuloplasty (BPV)

Pulmonary valve stenosis is a congenital cardiac condition characterized by narrowing of the pulmonary valve, leading to obstruction of blood flow from the right ventricle to the pulmonary artery. Depending on severity, patients may present with symptoms such as breathlessness, fatigue, or cyanosis in pediatric cases. Hemodynamically significant stenosis requires timely intervention to relieve the obstruction and reduce right ventricular pressure overload. In such cases, Balloon Pulmonary Valvuloplasty (BPV) is performed.

It is a minimally invasive procedure carried out via femoral venous access under fluoroscopic and echocardiographic guidance. A catheter is advanced into the main pulmonary artery for pressure assessment and angiographic delineation. The pulmonary valve is crossed using a guidewire, and an appropriately sized valvuloplasty balloon is positioned across the valve. The balloon is then dilated, relieving the valvular obstruction and improving blood flow across the pulmonary valve, with a reduction in the transvalvular gradient.This results in immediate hemodynamic improvement, symptomatic relief, and restoration of near-normal pulmonary valve function with minimal recovery time.

Note: This communication is intended for healthcare professionals (HCPs) in India and is for informational purposes only. It is not intended to provide medical advice or serve as a substitute for the independent medical judgment of an HCP.

At EuroPCR 2026, discover key clinical insights from the ALCHEMY Study—with 1000+ patients enrolled, reinforcing how ETE...
13/05/2026

At EuroPCR 2026, discover key clinical insights from the ALCHEMY Study—with 1000+ patients enrolled, reinforcing how ETERNIA Stent System continues to demonstrate reliability where it matters the most.

Unblock with Confidence.

📍 Venue: Room 343, Palais des Congrès de Paris, France
📅 Date: Thursday, 21st May 2026
⏰ Time: 16:15 – 16:20 IST

🎙️ Session Title:

Peri-Procedural Performance of Eternia Everolimus Eluting Coronary Stent : Real-World Experience

Join us for an exclusive scientific session featuring insights led by Dr. Upendra Kaul.

Note: This communication is intended for healthcare professionals (HCPs) in India and is for informational purposes only. It is not intended to provide medical advice or serve as a substitute for the independent medical judgment of an HCP.

A milestone worth celebrating🏆This EuroPCR 2026, Innvolution is proud to announce a major achievement with the ALCHEMY S...
11/05/2026

A milestone worth celebrating🏆

This EuroPCR 2026, Innvolution is proud to announce a major achievement with the ALCHEMY Study.

With 1000+ patients enrolled, this study marks a significant step forward in building robust clinical evidence for the Eternia Everolimus Eluting Coronary Stent System.

Note: This communication is intended for healthcare professionals (HCPs) in India and is for informational purposes only. It is not intended to provide medical advice or serve as a substitute for the independent medical judgment of an HCP.

11/05/2026

Ventricular Septal Defect (VSD)

A Ventricular Septal Defect (VSD) is a congenital cardiac condition characterized by an abnormal opening in the interventricular septum, resulting in left-to-right shunting of blood. Depending on the size and location of the defect, patients may present with symptoms such as breathlessness, recurrent respiratory infections, or failure to thrive, especially in pediatric cases. Hemodynamically significant defects require timely intervention to prevent complications such as pulmonary hypertension and cardiac overload.

In suitable cases, transcatheter VSD closure is performed as a minimally invasive alternative to surgery. The procedure is typically carried out via femoral access, under fluoroscopic and echocardiographic guidance. The defect is crossed using a guidewire, followed by advancement of a delivery sheath across the septum. An appropriately sized occluder device is then positioned and deployed, with sequential opening of discs on either side of the septum to achieve secure closure. Device positioning is carefully assessed before release to ensure stability and avoid interference with adjacent cardiac structures.

Post-deployment imaging is performed to confirm complete closure of the defect with no residual shunt. This approach enables effective defect management with reduced procedural risk, shorter recovery time, and improved patient outcomes.

Note: This communication is intended for healthcare professionals (HCPs) in India and is for informational purposes only. It is not intended to provide medical advice or serve as a substitute for the independent medical judgment of an HCP.

At Africa STEMI Live 2026, Fujifilm Innvolution is proud to present a comprehensive portfolio advancing precision in int...
07/05/2026

At Africa STEMI Live 2026, Fujifilm Innvolution is proud to present a comprehensive portfolio advancing precision in interventional cardiology.

From imaging to intervention, our solutions are designed to support clinicians across every stage of the PCI workflow:

PREMIER NV 30 – Floor-mounted single plane DSA cathlab with 30 × 30 cm detector for high-resolution imaging

Eternia – Everolimus Eluting Coronary Stent System designed to simplify navigation through complex coronary anatomies, delivering consistency and confidence in coronary interventions.

Clearpac - An advanced Paclitaxel-coated Drug-Coated Balloon (DCB) powered by ShellPac™️ Coating Technology, designed to enhance drug transfer and clinical effectiveness in coronary interventions.

Innvolith - Intravascular Lithotripsy System designed to redefine calcium management in complex coronary interventions.

InnvoLight OCT – AI-powered imaging for enhanced precision during PCI

📍 Argyle Grand Hotel, Nairobi, Kenya
📅 06–09 April 2026

Join us as we continue to enable better clinical decisions, improved procedural outcomes, and enhanced patient care.

Note: This communication is intended for healthcare professionals (HCPs) in India and is for informational purposes only. It is not intended to provide medical advice or serve as a substitute for the independent medical judgment of an HCP.

Something remarkable is on the horizon 💪 This EuroPCR 2026, Innvolution is set to bring forward insights that matter.Bui...
06/05/2026

Something remarkable is on the horizon 💪

This EuroPCR 2026, Innvolution is set to bring forward insights that matter.

Built on science. Driven by evidence. 📖
Designed to spark meaningful conversations. 💡

Stay tuned for what’s coming next.

Note: This communication is intended for healthcare professionals (HCPs) in India and is for informational purposes only. It is not intended to provide medical advice or serve as a substitute for the independent medical judgment of an HCP.

04/05/2026

FUJIFILM Innvolution Interventional Cardiology Business: 🚀Launched. Activated. What’s Next.

We had the privilege of bringing together partners and industry leaders for an exclusive gathering marking the launch of our Interventional Cardiology business in Middle East and Africa, in collaboration with Innvolution Healthcare Private Limited — a significant step in expanding our commitment to cardiovascular care across the region.

🎥Take a look back at a memorable evening that marked the beginning of a new chapter for in Interventional Cardiology.

Today, the momentum continues!

📍 Join us at Africa STEMI Live 2026 in Nairobi - Kenya
🗓️ 6 – 9 May 2026

Visit our FUJIFILM – Innvolution booth to explore our Interventional Cardiology portfolio, including:

* Cath Lab solutions
* Cardiac CT & MRI
* Drug eluting stents & balloons
* Cardiac ultrasound
* Synapse cardiology PACS
* OCT imaging
* IVL systems
* Radiation protection solutions

We look forward to reconnecting, building new partnerships, and continuing the conversation on democratizing cardiac care across the region!

Connect with our team to know more about our Interventional Cardiology solutions and for partnership opportunities:

Gaurav Agarwal Ashvini Suthar Atul Sharma Sachin Garg santosh girija nagarajarao Praveen Daga Ujjwal Bhardwaj Mostafa Amal Priten Patel Rajvinder singh hans Bablu sokhi Fuji Kenya Limited Meditec Systems Ltd Nairobi X-Ray Supplies Ltd

JOIN US TODAY!Join us for a power-packed LIVE WEBINAR – Life Beyond Metal, an educational initiative from the makers of ...
02/05/2026

JOIN US TODAY!

Join us for a power-packed LIVE WEBINAR – Life Beyond Metal, an educational initiative from the makers of Clearpac.

🎙 Speaker: Dr. Richa Sharma
🎓 Moderator: Dr. Shuvanan Ray
👥 Panelists: Dr. Ilankumaran.J ; Dr. Pretti Sharma
📅 Date: 2nd May 2026
⏰ Time: 7:00 – 8:00 PM

Don’t miss this insightful discussion by leading experts.

👉 Click the link https://medigene.in/InnvoClear/LBM2/ or Scan the QR code & register now!

Stay tuned for more updates.

Note: This communication is intended for healthcare professionals (HCPs) in India and is for informational purposes only. It is not intended to provide medical advice or serve as a substitute for the independent medical judgment of an HCP.

Address

Innvolution Healthcare Pvt. Ltd. #B-1012, Advant Navis Business Park Plot No-7, Greater Noida Expressway, Sector 142, Noida
Greater Noida
201305

Opening Hours

Monday 10am - 6pm
Tuesday 10am - 6pm
Wednesday 10am - 6pm
Thursday 10am - 6pm
Friday 10am - 6pm

Website

Alerts

Be the first to know and let us send you an email when Innvolution Healthcare posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category